Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation

Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation

Abstract Aims Therapy with phosphodiesterase‐5 inhibitors (PDE5Is) after left ventricular assist device (LVAD) implantation has been associated with lower mortality and device thrombosis but increased risk for post‐operative and gastrointestinal bleeding. We aimed to evaluate the impact of long‐term...

Full description

Bibliographic Details
Main Authors: Aiste‐Monika Jakstaite, Peter Luedike, Bastian Schmack, Nikolaus Pizanis, Matthias Riebisch, Alexander Weymann, Markus Kamler, Arjang Ruhparwar, Tienush Rassaf, Maria Papathanasiou
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Left ventricular assist devices
Sildenafil
Tadalafil
Phosphodiesterase‐5 inhibitors
Online Access:https://doi.org/10.1002/ehf2.13322

Internet

https://doi.org/10.1002/ehf2.13322

Similar Items